Lysozyme, a mediator of sepsis that intrinsically generates hydrogen peroxide to cause cardiovascular dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 3, 2009, Pages

  Mink, Steven N ^a,c   Jacobs, Hans ^a   Cheng, Zhao Qin ^a   Kasian, Krika ^a   Santos Martinez, Luis E ^b   Light, R Bruce ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Catalase; Compound I; Myocardial depression; Reactive oxygen species; Septic shock

Indexed keywords

CATALASE; GUANYLATE CYCLASE; HYDROGEN PEROXIDE; LYSOZYME; NITRIC OXIDE; SINGLET OXYGEN; SODIUM AZIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS NIGER; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOG; ELECTROCHEMISTRY; ENDOCARDIUM; ENZYME ACTIVATION; FLUOROMETRY; INFLAMMATION; MEDIATOR RELEASE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; SENSOR; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ASPERGILLUS NIGER; CARDIOVASCULAR DISEASES; CATALASE; DOGS; ENZYME INHIBITORS; HYDROGEN PEROXIDE; MURAMIDASE; MYOCARDIAL CONTRACTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; SHOCK, SEPTIC;

EID: 69249135509     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00732.2008     Document Type: Article

References (44)

1. 2 consumption. Am J Physiol Heart Circ Physiol 287: H14-H21, 2004.
2. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 365: 63-78, 2005.
3. Blinks JR. Field stimulation as a means of effecting the graded release of autonomic transmitters in isolated heart muscle. J Pharmacol Exp Ther 151: 221-235, 1966.
4. Buettner GR. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals. J Biochem Biophys Methods 16: 27-40, 1988.
5. Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol Heart Circ Physiol 252: H1267-H1273, 1987.
6. 2 by ethanol. Am J Physiol Heart Circ Physiol 258: H1267-H1273, 1990.
7. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 68: 26-36, 2005.
8. Chance B. The primary and secondary compounds of catalase and methyl or ethyl hydrogen peroxide: reactions with hydrogen peroxide. J Biol Chem 180: 947-959, 1949.
9. Chance B, Herbert D. The enzyme substrate compounds of bacterial catalase and peroxides. Biochem J 46: 402-414, 1950.
10. Cherry PD, Omar HA, Farrell A, Stuart JS, Wolin MS. Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am J Physiol Heart Circ Physiol 259: H1056-H1062, 1990.
11. Datta D, Vaidephi N, Xu X, Goddard WA. Mechanism for antibody catalysis of the oxidation of water by singlet dioxygen. Proc Natl Acad Sci USA 99: 2636-2641, 2002.
12. Dikalov S, Griendling K, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 49: 717-727, 2007.
13. Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73: 671-685, 1990.
14. Grobler JA, Rao R, Pervaiz S, Brew K. Sequences of two highly divergent canine type c lysozymes: implications for the evolutionary origins of the lysozyme/α-lactalbumin superfamily. Arch Biochem Biophys 313: 360-366, 1994.
15. Hancock TJ, Hsu JT. Thermal denaturation of lysozyme in a cosolvent studied by NMR. Biotechnol Prog 12: 494-502, 1996.
16. Hurst RG, Clark JB. The utility of the nitric oxide electrochemical sensor in biomedical research. Sensors 3: 321-329, 2003.
17. Jacobs H, Mink SN, Duke K, Bose D, Cheng ZQ, Howlett S, Ferrier GR, Light RB. Characterization of membrane N-glycan binding sites of lysozyme for cardiac depression in sepsis. Intensive Care Med 31: 129-137, 2005.
18. Jones P, Middlemiss DN. Formation of compound I by the reaction of catalase with peroxoacetic acid. Biochem J 130: 411-415, 1972.
19. Kramarenko GG, Hummel SG, Martin SM, Buettner GR. Ascorbate reacts with singlet oxygen to produce hydrogen peroxide. Photochem Photobiol 82: 1634-1637, 2006.
20. Lambeth JD, Kawahara T, Diebold B. Regulation of nox and duox enzymatic activity and expression. Free Radic Biol Med 43: 319-331, 2007.
21. Li X, Eschun G, Bose D, Jacobs H, Yang JJ, Light RB, Mink SN. Histamine H3 activation depresses cardiac function in experimental sepsis. J Appl Physiol 85: 1693-1701, 1998.
22. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, De Jonge HR. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 22: 307-312, 1997.
23. Loboda AV, Krutchinsky AN, Bromirski M, Ens W, Standing KG. A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance. Rapid Commun Mass Spectrom 14: 1047-1057, 2000.
24. Mason RP, Kubant R, Jacob R, Walter MF, Boychuk B, Malinski T. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: role of antioxidant activity. J Cardiovasc Pharmacol 48: 862-869, 2006.
25. Martyn KD, Fredericka LM, von Loehneysena K, Dinauerb MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18: 69-82, 2006.
26. Mink SN, Cheng ZQ, Bose R, Jacobs H, Kasian K, Roberts DE, Santos-Martinez LE, Light RB. Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Am J Physiol Heart Circ Physiol 293: H3140-H3149, 2007.
27. Mink SN, Kasian K, Jacobs H, Cheng ZQ, Light RB. N,N′ diacetylchitobiose, an inhibitor of lysozyme, reverses myocardial depression and lessens norepinephrine requirements in Escherichia coli sepsis in dogs. Shock 29: 681-687, 2008.
28. Mink SN, Kasian K, Santos Martinez LEF, Jacobs H, Bose R, Cheng ZQ, Light RB. Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation. Am J Physiol Heart Circ Physiol 294: H1724-H1735, 2008.
29. Mink SN, Bose R, Roberts DE, Jacobs H, Duke K, Bose D, Cheng ZQ, Light RB. Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric-oxide guanosine 3′,5′ monophosphate pathway in sepsis. J Mol Cell Cardiol 39: 615-625, 2005.
30. Mink SN, Jacobs H, Bose D, Duke K, Cheng ZQ, Liu G, Light RB. Lysozyme: a mediator of myocardial depression and adrenergic dysfunction in septic shock in dogs. J Mol Cell Cardiol 35: 265-275, 2003.
31. Mink SN, Jacobs H, Duke K, Bose D, Cheng ZQ, Light RB. N,N′,N triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in E coli sepsis in dogs. Crit Care Med 32: 184-193, 2004.
32. National Institutes of Health. Guide for the Care and Use of Laboratory Animals. [DHEW Publication No. (NIH) 85-23, Revised 1996, Office of Science and Health Reports, DRR/NIH, Bethesda, MD, 20205].
33. Nieva J, Wentworth P. The antibody-catalyzed water oxidation pathway-a new chemical arm to immune defense? Trends Biochem Sci 29: 274-278, 2004.
34. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100: 483-490, 1984.
35. Rand-Meir T, Dahlquist FW, Raftery MA. Use of synthetic substrates to study binding and catalysis by lysozyme. Biochemistry 8: 4206-4214, 1969.
36. Rupp H, Elimban B, Dhalla NS. Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. J Cardiovasc Pharmacol 24, Suppl 1: S16-S24, 1994.
37. Shugar D. Measurement of lysozyme activity and the ultra violet inactivation of lysozyme. Biochim Biophys Acta 8: 302-309, 1952.
38. Thomas SR, Chen K, Keaney JF. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase dependent signalling pathway. J Biol Chem 277: 6017-6024, 2002.
39. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 279: 34643-34654, 2004.
40. Wentworth AD, Jones LH, Wentworth P Jr, Janda KD, Lerner RA. Antibodies have the intrinsic capacity to destroy antigens. Proc Natl Acad Sci USA 97: 10930-10935, 2000.
41. Wentworth P, Jones LH, Wentworth AD, Zhu X, Larsen NA, Wilson IA, Xu X, Goddard WA, Janda KD, Eschenmoser A, Lerner RA. Antibody catalysis of the oxidation of water. Science 293: 1806-1811, 2001.
42. Wentworth P, McDunn Wentworth AD, Takeuchi C, Nieva J, Jones T, Bautista C, Ruedi JM, Guttierrez A, Janda KD, Babior Bernard M, Eschenmoser A, Lerner RA. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 298: 2195-2199, 2002.
43. Wentworth P, Wentworth AD, Zhu X, Wilson IA, Janda KD, Eschenmoser A, Lerner RA. Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens. Proc Natl Acad Sci USA 100: 1490-1493, 2003.
44. Zhang X. Real time and in vivo monitoring of nitric oxide by electrochemical sensors from dream to reality. Front Biosci 9: 3434-3446, 2004.